Live Breaking News & Updates on Thoracic Cancers

Stay updated with breaking news from Thoracic cancers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Schneider on Treatment Considerations After Osimertinib in EGFR+ NSCLC

Jaime Schneider, MD, PhD, discusses considerations for patients with EGFR-mutant non–small cell lung cancer that progresses on osimertinib.

....

United States , Jaime Schneider , Harvard Medical School , Thoracic Cancers , Massachusetts General Hospital , Egfr Mutant Non Small Cell Lung Cancer ,